RemovAid AS

RemovAid AS specialises in medical devices designed specifically for the removal of subdermal implants. Their primary focus is on creating tools for extracting contraceptive implants, which are commonly inserted under the skin for long-term birth control. These devices are engineered to enable healthcare providers to perform the procedure in a minimally invasive way, reducing discomfort for patients.

RemovAid AS is headquartered in Oslo, Norway. While the company’s devices are intended for global use, its primary focus is on addressing the needs of healthcare providers and patients in regions where contraceptive implant removal is a common procedure. The company’s mission centres on improving the ease and gentleness of this process for both women and medical professionals.

RemovAid AS’s devices are registered in the eudamed database, which is the official EU registry for medical devices. This listing ensures transparency and compliance with EU regulatory requirements for Class IIa devices, which include those designed for procedures like subdermal implant removal.

RemovAid AS’s devices fall under EU Class IIa classification. This classification is assigned based on factors like the device’s intended use, potential risks, and the invasiveness of the procedure it facilitates. Class IIa devices require conformity assessment procedures to ensure safety and performance, including clinical evaluations where necessary.